Active	Status	Sponsor type	Region	Phase	Filter
5 Active 4 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Grekin, Steven
SCALP2, NCT05914805: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss	Recruiting	3	726	Europe, US	Clascoterone 5% solution, CB-03-01 5% solution, Vehicle solution, Vehicle	Cassiopea SpA, Ergomed PLC, Pharmapace Inc, Canfield Scientific Inc., ICON Clinical Research	Alopecia, Androgenetic	08/24	03/25
NCT06088043: A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment	Active, not recruiting	3	693	Europe, Canada, Japan, US, RoW	TAK-279, Placebo, Apremilast	Takeda	Plaque Psoriasis	08/25	04/26
NCT05772520: The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis	Recruiting	2	120	US	TLL018 tablets, TLL018 Placeboes	Hangzhou Highlightll Pharmaceutical Co., Ltd	Plaque Psoriasis	04/24	05/24
NCT05399368: An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis	Terminated	2	229	Canada, US	RPT193, Placebo	RAPT Therapeutics, Inc.	Atopic Dermatitis	05/24	05/24
TONE, NCT05971381: Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells	Active, not recruiting	N/A	109	US	RECELL® Autologous Cell Harvesting Device, Spray-On SkinTM Cells	Avita Medical	Vitiligo	07/24	01/25